# A Study of LY3337641 in Japanese and Caucasian Healthy Participants

> **NCT03083561** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3337641
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03083561
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-15
- **Primary completion:** 2017-05-25
- **Final completion:** 2017-05-25
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03083561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03083561, "A Study of LY3337641 in Japanese and Caucasian Healthy Participants". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03083561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*